by QFR Solutions | Mar 25, 2019 | News
Source: GlobeNewswire Leverkusen, Germany, March 25, 2019 (GLOBE NEWSWIRE) — Biofrontera Inc., USA (“Biofrontera”), a wholly owned subsidiary of Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), today entered into an agreement to acquire all...
by QFR Solutions | Mar 15, 2019 | News
Source: FierceBiotech Stryker has acquired OrthoSpace, developers of a therapy for severely torn rotator cuffs, in a deal worth up to $220 million, split evenly between upfront cash and future milestone payments. The Israel-based OrthoSpace has developed a...
by QFR Solutions | Feb 28, 2019 | News
Source: PR Newswire PRINCETON, N.J., Feb. 27, 2019 /PRNewswire/ — Sun Pharmaceutical Industries Inc., USA (SPII) today announced that it plans to present 19 abstracts featuring data on ILUMYA™ (tildrakizumab-asmn), a prescription medicine used to treat adults...
by QFR Solutions | Feb 8, 2019 | News
Source: FierceBiotech Medtronic has received approval of an expanded indication from the FDA for its Pipeline Flex embolization device, for patients with smaller aneurysms found deeper in the brain. The system was previously approved for endovascular treatment with...
by QFR Solutions | Jan 30, 2019 | News
Source: FierceHealthcare Anthem is planning to begin moving members into its new PBM, IngenioRx, in the second quarter of 2019, bumping up the projected launch from 2020. Anthem announced the change as part of its fourth-quarter earnings (PDF), saying it moved...
